EDIT:NASDAQ
Editas Medicine Inc
၁.၈၇ US$
၀.၀၀%
(၀.၀၀) 1D
နို ၁၇, GMT-၅ ၁၁:၀၆:၅၀ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
၁.၉၀ US$
High
၁.၉၄ US$
Low
၁.၈၂ US$
Mkt. cap
၂၈.၈၆ ကုဋေ
Avg. vol.
၂.၄၁ သန်း
Volume
၄.၂၇ သိန်း
52-wk high
၃.၉၄ US$
52-wk low
၁.၆၆ US$
EPS
-၀.၆၂ US$
Beta
၂.၀၉
Shares outstanding
၁၅.၄၃ ကုဋေ
No. of employees
၈၇
Open
၁.၉၀ US$
High
၁.၉၄ US$
Low
၁.၈၂ US$
Mkt. cap
၂၈.၈၆ ကုဋေ
Avg. vol.
၂.၄၁ သန်း
Volume
၄.၂၇ သိန်း
52-wk high
၃.၉၄ US$
52-wk low
၁.၆၆ US$
EPS
-၀.၆၂ US$
Beta
၂.၀၉
Shares outstanding
၁၅.၄၃ ကုဋေ
No. of employees
၈၇
News stories
From web sources and news partners
TradingView
·
ပြီးခဲ့သည့် ၁ နာရီ
Wells Fargo sets 2027 S&P 500 year-end target at 8,200
Coinpaper
·
ပြီးခဲ့သည့် ၁ နာရီ
Stock Market Today: S&P 500 Struggles Ahead of Nvidia Earnings After $2 Trillion Stock Rout
qz.com
·
ပြီးခဲ့သည့် ၃ နာရီ
5 Nasdaq-linked stock indexes and how each differs from the S&P 500
StoneX
·
ပြီးခဲ့သည့် ၂ နာရီ
S&P 500 forecast: Why US stocks have largely defied gravity and what could trigger a correction
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc